Latest Strategic Outlook News

Infini Resources has identified extensive shallow bedrock conductors over 10 km long at its Reynolds Lake Uranium Project, signalling promising near-surface uranium mineralisation in a historically underexplored region of the Athabasca Basin.

Deep Yellow Limited reports significant progress at its flagship Tumas uranium project in Namibia and successful pilot testing at Mulga Rock in Australia, supported by a robust cash position of A$217.4 million.

Rimfire Pacific Mining has secured $3.5 million through a discounted share placement to accelerate scandium resource development across its NSW projects, signaling renewed momentum after arbitration setbacks.

Peter Warren Automotive Holdings signals a stronger finish to FY25 with an expected $22 million underlying profit, driven by strategic marketing and cost efficiencies. Investors await the full results due in August.

American West Metals reports significant copper sulphide discoveries and thick mineralised intersections at its Storm Copper Project in Nunavut, Canada, highlighting strong potential for resource expansion.

Austco Healthcare reports robust FY25 growth with revenue climbing over 37% and EBITDA soaring by more than 54%, fueled by strong organic performance and key acquisitions.

Emerald Resources NL has reported a substantial increase in gold mineral resources at its Memot and Dingo Range projects, advancing its goal to become a multi-mine gold producer.

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.

Westgold Resources reported a strong finish to FY25 with 82km of drilling and a $9 million investment in exploration, highlighted by a maiden 2.3 million ounce gold resource at Beta Hunt’s Fletcher zone.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.

InhaleRx Limited has secured key ethics approvals and initiated manufacturing for its inhaled drug candidates targeting breakthrough cancer pain and panic disorder, supported by a $38.5 million funding facility to accelerate development.